What are the Factors Influencing UFE Success and Longevity?

Uterine Fibroid Embolisation (UFE), also known as Uterine Artery Embolisation (UAE), has emerged as a minimally invasive and highly effective treatment for symptomatic uterine fibroids. For many South African women grappling with the debilitating effects of fibroids, UFE offers a compelling alternative to traditional surgical interventions like hysterectomy or myomectomy. You might be one of these women facing a choice of what treatment is right for you. Understanding the nuances that contribute to the factors influencing UFE success and its long-term efficacy is crucial for both patients and healthcare providers.

This article delves into the scientific literature to explore the various elements that play a significant role in how long UFE lasts, the long-term outcomes of fiibroid embolisation and sustained benefits, drawing insights from medical journals and studies.

Defining UFE Success: More Than Just Fibroid Shrinkage

When discussing UFE, ‘success’ encompasses more than just the physical reduction in fibroid size. It primarily refers to a significant improvement in symptoms, enhanced quality of life, and the avoidance of further interventions. Studies indicate a high technical success rate for UAE, often exceeding 95%, leading to a measurable elimination of abnormal uterine bleeding in over 90% of treated women and an 80-90% satisfaction rate.

However, long-term success also considers the durability of symptom relief and the need for re-intervention. Although there are substantial improvements, some research indicates that by the third year post-treatment, UFE’s symptom improvement and health-related quality of life gradually fall, comparable to myomectomy, but still far better than baseline.

Key Factors Influencing UFE Success and Longevity

Several interconnected factors contribute to the overall success and longevity of UFE. These can broadly be categorised into patient characteristics, fibroid characteristics, and procedural aspects.

Patient Characteristics

Individual patient factors can significantly impact UFE outcomes:

• Age: While UFE is extensively used in premenopausal women, studies also explore its efficacy in older demographics. Increasing age has been associated with lower odds of undergoing UFE versus hysterectomy.
• Previous Myomectomy: A history of myomectomy has been identified as a factor that negatively affects UFE results, increasing the likelihood of failure.
• Obesity (BMI > 30): Clinical obesity is a significant predictor of increased risk for post-UFE infection, which can compromise the success of the procedure.
• Overall Health: General health status and pre-existing medical conditions can influence recovery and overall satisfaction.

Fibroid Characteristics

The nature of the fibroids themselves plays a critical role:

• Size and Volume: Larger uterine volume or dominant fibroid size are correlated with a higher late surgical conversion rate, indicating a lower long-term success rate. Similarly, uterine volume exceeding 1000cm³ increases the risk of post-UFE infection.
• Location: The location of fibroids (e.g., submucosal, intramural, subserosal) can influence the type of symptoms experienced and potentially the response to embolisation. For instance, submucosal fibroids are more prone to expulsion after UFE.
• Number of Fibroids: While not explicitly detailed in all reviewed studies as a direct failure predictor, the complexity associated with multiple fibroids might influence outcomes.

Procedural Aspects

The technical execution and immediate post-procedural management are vital:

• Technical Success of Embolisation: A high technical success rate (>95%) is crucial for effective fibroid devascularisation.
• Embolisation Technique: The type of embolic agent and the technique used by the interventional radiologist can influence the extent of fibroid infarction and long-term outcomes.
• Post-procedural Pain Management: Effective management of post-procedural pain is essential for patient comfort and recovery, although it does not directly correlate with long-term success.

Post-procedural Care and Follow-up

Long-term monitoring and patient adherence to follow-up protocols are important for assessing longevity:

• Regular Follow-up: Consistent follow-up, often involving MRI and patient questionnaires, helps monitor fibroid shrinkage, perfusion changes (how blood flow is altered in the uterus and fibroids following the procedure), and symptom relief over time.
• Sustained Symptom Control: UFE is associated with sustained long-term symptom control, with significant reductions in myoma size and perfusion, and unaffected healthy uterine tissue.

Conclusion

Uterine Fibroid Embolisation stands as a highly effective treatment option for symptomatic uterine fibroids, offering significant improvements in quality of life and symptom relief. The success and longevity of UFE are influenced by a combination of patient-specific factors, fibroid characteristics, and meticulous procedural execution, alongside diligent post-procedural care.

While UFE boasts impressive success rates, particularly in the short to mid-term, understanding the potential for gradual decline in symptom improvement over several years and identifying risk factors like previous myomectomy, obesity, and large uterine volume are imprtant to consider with your healthcare provider. Empower yourself by consulting with UFE specialists in South Africa to make informed decisions, optimising the chances of a successful and lasting outcome from UFE.

____________________________________________________References

[1] Ubaldi, N., Tipaldi, M. A., Giannini, A., et al. (2025). Uterine fibroid embolization: An analysis of clinical outcomes and impact on patients’ quality of life. Open Med (Wars). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12355358/ [2] Huang, J. Y. J. (2006). Failure of uterine fibroid embolization. Fertility and Sterility, 85(1), 30-35. Available at: https://www.sciencedirect.com/science/article/pii/S0015028205036575 [3] Anchan, R. M., Spies, J. B., Zhang, S., et al. (2023). Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids. Am J Obstet Gynecol. Available at: https://pubmed.ncbi.nlm.nih.gov/37244458/ [4] Mollier, J., Patel, N. R., Amoah, A., et al. (2020). Clinical, Imaging and Procedural Risk Factors for Intrauterine Infective Complications After Uterine Fibroid Embolisation: A Retrospective Case Control Study. Cardiovasc Intervent Radiol, 43(12), 1910-1917. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7649153/ [5] D’hoore, T., Timmerman, D., Laenen, A., et al. (2020). Long-term outcome and pre-interventional predictors for late intervention after uterine fibroid embolization. European Journal of Obstetrics & Gynecology and Reproductive Biology, 247, 149-155. Available at: https://www.sciencedirect.com/science/article/abs/pii/S0301211520300877